Tags : Malaysia

ViewPoints Interview: Impact of new regulations and trends in the

Vartika Singh February 28, 2020

The Medical Devices Conference was hosted by DIA India on 21st and 22nd February in collaboration with the Medical Technology Association of India (MTaI), AIC-AMTZ Medivalley Incubation Council and mDI […]readmore

Biosimilars Regulatory

Biocon Receives EU’s GMP Certification for its Semglee (biosimilar,

Tuba Khan August 22, 2019

Shots: Biocon has received EMA’s certificate of GMP compliance from European inspection authority, Health Products Regulatory Authority (Ireland) and expand its capacities multi-fold with the new large-scale devices facility to […]readmore

Tags : Malaysia

ViewPoints Interview: Impact of new regulations and trends in the

Biocon Receives EU’s GMP Certification for its Semglee (biosimilar,

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Malaysia

ViewPoints Interview: Impact of new regulations and trends in the

﻿ Biocon Receives EU’s GMP Certification for its Semglee (biosimilar,

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company

Biocon Receives EU’s GMP Certification for its Semglee (biosimilar,